Scilex Holding Co (SCLX)
0.6781
-0.06
(-8.36%)
USD |
NASDAQ |
Nov 14, 16:00
0.67
-0.01
(-1.19%)
After-Hours: 20:00
Scilex Debt to Equity Ratio: -0.4863 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.4863 |
| March 31, 2024 | -0.5756 |
| December 31, 2023 | -0.7255 |
| September 30, 2023 | -0.7509 |
| Date | Value |
|---|---|
| June 30, 2023 | 3.298 |
| March 31, 2023 | 0.8667 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.4788 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.7509
Minimum
Sep 2023
3.298
Maximum
Jun 2023
0.1435
Average
-0.4826
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| Masimo Corp | 0.528 |
| Oramed Pharmaceuticals Inc | -- |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 104.54M |
| Total Liabilities (Quarterly) | 319.24M |
| Shareholders Equity (Quarterly) | -214.69M |
| Current Ratio | 0.1974 |
| Net Debt Paydown Yield | -8.09% |